Recent Updates
Recently added Catalysts
TWST Positive Sentiment

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference

Wednesday, September 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Twist Bioscience Corporation announced that its CEO, Dr. Emily M. Leproust, and CFO, Adam Laponis, will participate in a fireside chat at the Baird 2026 Global Healthcare Conference. The event is scheduled for September 15, 2026, and will be webcast live, allowing broader access to the discussion.

Market Sentiment Analysis

POSITIVE FACTORS

  • Twist Bioscience is actively engaging with investors.
  • Participation in a prominent healthcare conference highlights company visibility.
  • Leadership involvement suggests confidence in future growth.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026 at 1:25 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the “In

Frequently Asked Questions

When is Twist Bioscience presenting at the conference?

Twist Bioscience will present on September 15, 2026.

Who will represent Twist Bioscience at the conference?

Dr. Emily M. Leproust and Adam Laponis will represent the company.

Where is the Baird 2026 Global Healthcare Conference held?

The conference will take place in New York City.

Will the presentation be available online?

Yes, the fireside chat will be webcast live.

ShareAdd on Google
Tags: TWST Viatris Investor Conferences Healthcare Twist Bioscience Baird 2026 healthcare conference Emily Leproust Adam Laponis
Last updated: Sep 9, 2026

Biotech snapshot

Cash runway
$167M liquidity · $0M/mo burn
Low dilution risk